1. Identification of prognostic biomarkers of prostate cancer with long non-coding RNA-mediated competitive endogenous RNA network
   Guomei Ye et al, 2019, Experimental and Therapeutic Medicine CrossRef
2. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis
   Almut Dutz et al, 2019, Acta Oncologica CrossRef
3. Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial
   Motohiro Murakami et al, 2024, Journal of Radiation Research CrossRef
4. Chronoradiation Therapy for Prostate Cancer: Morning Proton Beam Therapy Ameliorates Worsening Lower Urinary Tract Symptoms
   Hiromitsu Negoro et al, 2020, Journal of Clinical Medicine CrossRef
5. Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer
   Takashi Iizumi et al, 2022, Journal of Medical Radiation Sciences CrossRef
6. Proton Radiation Therapy: A Systematic Review of Treatment-Related Side Effects and Toxicities
   Peter P. Salem et al, 2024, International Journal of Molecular Sciences CrossRef
7. Variation of the relative biological effectiveness with fractionation in proton therapy: Analysis of prostate cancer response
   Juan Pardo‐Montero et al, 2023, Medical Physics CrossRef
8. A Literature Review of Proton Beam Therapy for Prostate Cancer in Japan
   Rika Maglente Hoshina et al, 2019, Journal of Clinical Medicine CrossRef
9. Consensus Statement on Proton Therapy for Prostate Cancer
   Curtis M. Bryant et al, 2021, International Journal of Particle Therapy CrossRef
10. Prediction of radiation‐induced malfunction for cardiac implantable electronic devices (CIEDs)
    Hiroaki Matsubara et al, 2020, Medical Physics CrossRef